Publications by authors named "Thomas C Merigan"

26Publications

Role of Physician-Scientists in the Control of Human Immunodeficiency Virus.

Authors:
Thomas C Merigan

J Infect Dis 2018 08;218(suppl_1):S3-S6

George E. and Lucy Becker Professor of Medicine Emeritus, Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, California.

View Article and Find Full Text PDF
August 2018

In vitro HIV-1 evolution in response to triple reverse transcriptase inhibitors & in silico phenotypic analysis.

PLoS One 2013 17;8(4):e61102. Epub 2013 Apr 17.

Department of Pediatrics, Division of Pneumonology-Immunology, Charité University Medical Center, Berlin, Germany.

View Article and Find Full Text PDF
November 2013

Persistence versus reversion of 3TC resistance in HIV-1 determine the rate of emergence of NVP resistance.

Viruses 2012 08 7;4(8):1212-34. Epub 2012 Aug 7.

Center for AIDS Research, Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine, Stanford, CA 94305, USA.

View Article and Find Full Text PDF
August 2012

"Wide-open" 1.3 A structure of a multidrug-resistant HIV-1 protease as a drug target.

Structure 2005 Dec;13(12):1887-95

Department of Biochemistry and Molecular Biology, Wayne State University School of Medicine, Detroit, Michigan 48201, USA.

View Article and Find Full Text PDF
December 2005

Pharmacokinetics of nelfinavir and efavirenz in antiretroviral-naive, human immunodeficiency virus-infected subjects when administered alone or in combination with nucleoside analog reverse transcriptase inhibitors.

Antimicrob Agents Chemother 2005 Aug;49(8):3558-61

Adult ACTG Pharmacology Support Laboratory, Laboratory for Antiviral Research, Department of Pharmacy Practice, School of Pharmacy and Pharmaceutical Sciences, University at Buffalo, Buffalo, NY 12460, USA.

View Article and Find Full Text PDF
August 2005

Antiviral activity of lamivudine in salvage therapy for multidrug-resistant HIV-1 infection.

Clin Infect Dis 2005 Jul 7;41(2):236-42. Epub 2005 Jun 7.

Division of Infectious Diseases, Department of Medicine, University of Colorado Health Sciences Center, Denver 80262, USA.

View Article and Find Full Text PDF
July 2005

Insertions in the human immunodeficiency virus type 1 protease and reverse transcriptase genes: clinical impact and molecular mechanisms.

Antimicrob Agents Chemother 2005 Jul;49(7):2575-82

Division of Infectious Diseases and Geographic Medicine, Stanford University, 300 Pasteur Drive, Room S-146, Stanford, California 94305-5107, USA.

View Article and Find Full Text PDF
July 2005

New two-amino acid insertion near codon 70 of the HIV type 1 protease gene.

AIDS Res Hum Retroviruses 2005 Apr;21(4):311-3

Division of Infectious Diseases, Stanford University Medical Center, Stanford, California 94305, USA.

View Article and Find Full Text PDF
April 2005

Human immunodeficiency virus type 1 infection in Oman: antiretroviral therapy and frequencies of drug resistance mutations.

AIDS Res Hum Retroviruses 2004 Nov;20(11):1166-72

Department of Microbiology and Immunology, College of Medicine and Health Sciences, Sultan Qaboos University, Muscat, PC 123 Oman.

View Article and Find Full Text PDF
November 2004

Association of a novel human immunodeficiency virus type 1 protease substrate cleft mutation, L23I, with protease inhibitor therapy and in vitro drug resistance.

Antimicrob Agents Chemother 2004 Dec;48(12):4864-8

Division of Infectious Diseases, Department of Medicine, Stanford University, Stanford, California 94305, USA.

View Article and Find Full Text PDF
December 2004